Modern medical research has lead to a continuous growth in understanding of pathological aberrations. This understanding is the basis of the development of innovative diagnostic products with prognostic, predicative and therapeutic value by ZytoVision®.
ZytoVision GmbH was founded on the 24th of May 2004 in Bremerhaven, Germany, and is headed by its two founders Dr. Piere Rogalla (left) and Dr. Sven Hauke (right).
